SigTuple, a medtech startup, has raised Rs 33 crore (USD 4 million) in an extended Series C round. SIDBI Venture Capital led the funding, which included existing investors such as Endiya Partners and strategic leaders from the healthcare sector.

The Bengaluru-based company previously secured USD 4.3 million in its Series C round led by Endiya Partners and Accel in March 2023. So far, the firm has raised over USD 40 million.

According to a press release from SigTuple, the proceeds will be used for geographical expansion, expanding the product portfolio, and obtaining regulatory clearances.

SigTuple was founded in 2015 by Apurv Anand, Bharath Cheluvaraju, Rohit Kumar Pandey, and Tathagata Dastidar. SigTuple specializes in AI-driven smart robotic microscopes for automating manual processes in clinical laboratories. 

Since 2020, the company has focused on its core product, gaining traction in the Indian market with major diagnostics industry players as customers.

SigTuple has expanded its reach into Southeast Asia, the Middle East, and North Africa by partnering with Horiba Medical as its distribution channel for South Asia. 

The company plans to enter Europe and the Americas. In September 2023, SigTuple became the third company globally and the first in India to receive US approval for AI-assisted digital haematology.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app today and 10x your trading & investing journey!